Press releases
- Nordic Nanovector Provides Update on LYMRIT 37-05 Phase 1 DLBCL Trial
- Nordic Nanovector ASA: Allocation of PSUs
- Nordic Nanovector: New preclinical Data Offer Insights Into Enhancing Betalutin®-Based Therapies in NHL
- Nordic Nanovector ASA - Financial Calendar
- Nordic Nanovector ASA - Results for the Third Quarter 2019
- Nordic Nanovector to Participate in Four Upcoming Investor Conferences
- Nordic Nanovector ASA: Invitation to Third Quarter 2019 Results Presentation and Webcast
- Nordic Nanovector ASA: Mandatory Notification of Trade - Primary Insider
- Nordic Nanovector ASA - Resolution not to Proceed With a Repair Offering
- Nordic Nanovector ASA - Tranche 1 Share Capital Increase Registered
More ▼
Key statistics
Markit short selling activity
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 57.32m |
Free float | 48.39m |
P/E (TTM) | -- |
Market cap | 1.61bn NOK |
EPS (TTM) | -7.23 NOK |
Data delayed at least 15 minutes.
More ▼